Intelligent Bio Solutions announced a 46% year-over-year revenue increase in fiscal Q3 2026, reaching $1.06 million, with cartridge sales up 59% and representing 66% of revenue. The company improved its gross profit margin to over 50%, reflecting operational efficiencies and a growing installed base driving recurring consumable demand. With ongoing FDA regulatory progress and new partnerships, Intelligent Bio Solutions is positioned for continued growth in the multi-billion-dollar U.S. drug screening market. Marketing investments have boosted revenue growth while becoming more efficient, supporting the company's expanding footprint in safety-critical industries globally.
Sodexo has secured a major global contract to provide catering services across more than 130 Meta sites in over 30 countries. This large-scale partnership includes diverse locations such as headquarters, campuses, data centers, and conference centers...
XRP surged about 4% to $1.11 following a broader crypto market rebound triggered by softer U.S. inflation data. Technical signals suggest a bullish inverse head and shoulders pattern, with potential for a 20% price increase if XRP breaks the $1.12–$1...
Revolut has received preliminary approval from Dubai's Virtual Assets Regulatory Authority to offer cryptocurrency services in the UAE, including broker-dealer, asset management, and exchange functions. This approval allows UAE customers to trade and...
Rotork PLC has accepted a £4.1 billion takeover bid from Swiss engineering group ABB, offering shareholders 506p per share, a 73% premium over the previous closing price. The acquisition will enhance ABB's industrial automation business by adding Rot...
Alexandria Real Estate Equities (ARE) is struggling with oversupply and vacancy rates exceeding 30% in key life science markets like Boston, San Francisco, and San Diego. This has caused an 80% decline in its stock price from its peak. The company's ...
